$5.16
1.53%
Nasdaq, Fri, Nov 15 2024
ISIN
CA35954B2066
Symbol
HUGE

FSD Pharma Inc Stock price

$5.16
+0.36 7.50% 1M
-16.00 75.61% 6M
-54.63 91.37% YTD
-70.24 93.16% 1Y
-97.54 94.98% 3Y
-323.09 98.43% 5Y
-1,121.04 99.54% 10Y
Nasdaq, Closing price Fri, Nov 15 2024
-0.08 1.53%
ISIN
CA35954B2066
Symbol
HUGE

Key metrics

Market capitalization $9.73m
Enterprise Value $2.55m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 0.60
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-11.78m
Free Cash Flow (TTM) Free Cash Flow $-6.73m
Cash position $6.61m
EPS (TTM) EPS $-14.87
P/S forward 10.24
EV/Sales forward 2.68
Short interest 0.44%
Show more

Is FSD Pharma Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

FSD Pharma Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast FSD Pharma Inc:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast FSD Pharma Inc:

Buy
100%

Financial data from FSD Pharma Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
- -
-
100%
- Direct Costs 0.50 0.50
86% 86%
-
-0.50 -0.50
86% 86%
-
- Selling and Administrative Expenses 9.01 9.01
12% 12%
-
- Research and Development Expense 1.77 1.77
73% 73%
-
-11 -11
45% 45%
-
- Depreciation and Amortization 0.50 0.50
86% 86%
-
EBIT (Operating Income) EBIT -12 -12
51% 51%
-
Net Profit -10 -10
54% 54%
-

In millions USD.

Don't miss a Thing! We will send you all news about FSD Pharma Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

FSD Pharma Inc Stock News

Positive
InvestorPlace
3 months ago
FSD Pharma (NASDAQ: HUGE ) stock is taking off on Friday after the biopharmaceutical company provided investors with an update on its investment in Celly Nutrition . FSD Pharma notes that Celly Nutrition is closing in on the launch of its “unbuzzd” product.
Neutral
Accesswire
3 months ago
TORONTO, ON / ACCESSWIRE / August 9, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update on its investment in Celly Nutrition Corp. ("Celly Nu"), a privately held Canadian company launching an innovative beverage product that can assist in Expediting Alcohol Metabolism and Faster Recovery from Alcohol Consumption. On August 9, 2024, Celly Nutrition which ...
Neutral
Accesswire
5 months ago
TORONTO, ON / ACCESSWIRE / June 28, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions is pleased to provide the following corporate update. Corporate Update FSD Pharma has retained the services of Totaligent, Inc. ("Totaligent") who will play a key rol...
More FSD Pharma Inc News

Company Profile

FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for various central nervous system disorders, including chronic pain, fibromyalgia, and irritable bowel syndrome. FSD Pharma Inc. has a strategic alliance agreement with SciCann Therapeutics Inc. for the production and distribution of cannabinoid-based, patent pending, and indication-specific products; and collaborative research and development agreement with Solarvest BioEnergy Inc. The company is headquartered in Cobourg, Canada.

Head office Canada
CEO Zeeshan Saeed
Founded 1994
Website www.fsdpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today